Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021

Rhea-AI Summary

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will report its financial results for Q2 2021 on August 5, 2021, after market close. The management will host a conference call at 4:30 PM ET for discussions on the results. Interested parties can join by dialing 888-394-8218 in the U.S. or 323-794-2588 internationally. Opiant develops medications for addictions and drug overdose, including the NARCAN® Nasal Spray. More information can be found on their official website.

Positive

• Opiant has developed NARCAN® Nasal Spray, a leading product in the addiction treatment market.

Negative

• None.

SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the second quarter ended June 30, 2021, after the financial markets close on Thursday, August 5, 2021.

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday, August 5, 2021. To access the call, please dial 888-394-8218 in the U.S. or 323-794-2588 outside the U.S. and provide the conference ID number: 5960603. To access the live webcast, please visit http://public.viavid.com/index.php?id=145669. Following the live webcast, an archived version of the call will be available on the website.

Thursday August 5 @ 4:30 pm ET

Domestic:	888-394-8218
International:	323-794-2588
Conference ID:	5960603
Webcast:	http://public.viavid.com/index.php?id=145669

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com

FAQ

When will Opiant report its Q2 2021 financial results?

Opiant will report its Q2 2021 financial results on August 5, 2021, after market close.

What time is Opiant's conference call for Q2 2021 results?

Opiant's conference call for Q2 2021 results is scheduled for 4:30 PM ET on August 5, 2021.

How can I access Opiant's Q2 2021 earnings call?

You can access Opiant's Q2 2021 earnings call by dialing 888-394-8218 in the U.S. or 323-794-2588 internationally.

What is the focus of Opiant Pharmaceuticals?

Opiant Pharmaceuticals focuses on developing medicines for addictions and drug overdose.

What is NARCAN® Nasal Spray?

NARCAN® Nasal Spray is a medication developed by Opiant for reversing opioid overdoses.